Science Based Criteria BE IVIV Bio Waivers and STrategic Framework
35286540 Dr Redddy s Lab Product Analysis in Urban Market DELHI
Firstcall recommend this pharma scrip after 113.08% y/y upsurge in Q4FY15 net profits
BSE:524715 NSE:SUNPHARMA Bloomberg: SUNP@IN Reuters: SUN.BO Creating Lasting Value Investor Presentation- November 2011.
Creating Lasting Value Investor Presentation- May 2011.
